This webinar considers barriers to clinical trial enrollment, including trial design, inclusion/exclusion criteria, language barriers, and financial toxicity, and how organizations are working to increase enrollment of patients from diverse communities.
This covers the clinical evidence and rationale for focal dose escalation to the MRI-defined GTV in prostate cancer. We will also review real clinical cases to learn the best way to identify the GTV and contour for radiotherapy planning. Dosimetric constraints and pitfalls will be considered.
Facebook
Twitter
LinkedIn
Forward
